Validation of Serum Biomarkers Derived from Proteomic Analysis for the Early Screening of Preeclampsia

Abstract

sVCAM-1 and Pappalysin-1 do not improve early screening for PE. Cystatin-C, however, seems to be associated with subsequent PE development, but larger studies are necessary to validate these findings.